Unknown

Dataset Information

0

Chaperone proteins as ameliorators of α-synuclein-induced synaptic pathologies: insights into Parkinson's disease.

ABSTRACT:

SUBMITTER: Banks SML 

PROVIDER: S-EPMC8224136 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Chaperone proteins as ameliorators of α-synuclein-induced synaptic pathologies: insights into Parkinson's disease.

Banks Susan M L SML   Medeiros Audrey T AT   Sousa Rui R   Lafer Eileen M EM   Morgan Jennifer R JR  

Neural regeneration research 20210601 6

Similar Datasets

Unknown Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
| S-EPMC5526979 | biostudies-literature
Unknown Optogenetic-induced α-synuclein accumulation reveals early synaptic dysfunction in experimental models of Parkinson's disease.
| S-EPMC12738572 | biostudies-literature
Unknown Structural and functional insights into the nuclear role of Parkinson's disease-associated α-synuclein as a histone chaperone.
| S-EPMC12062221 | biostudies-literature
Unknown Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson's disease.
| S-EPMC8867846 | biostudies-literature
Unknown Longitudinal multi-omics in alpha-synuclein Drosophila model discriminates disease- from age-associated pathologies in Parkinson's disease.
| S-EPMC11897226 | biostudies-literature
Unknown Amelioration of pathologic α-synuclein-induced Parkinson's disease by irisin.
| S-EPMC9457183 | biostudies-literature
Unknown Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.
| S-EPMC3615743 | biostudies-literature
Unknown A Matrigel-based 3D construct of SH-SY5Y cells models the α-synuclein pathologies of Parkinson's disease.
| S-EPMC8922027 | biostudies-literature
Unknown Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
| S-EPMC2879277 | biostudies-literature
Unknown Comparing GBA1-Parkinson's disease and idiopathic Parkinson's disease: α-Synuclein oligomers and synaptic density as biomarkers in the skin biopsy.
| S-EPMC11483590 | biostudies-literature